Lifecore Biomedical (LFCR) vs Vanda Pharmaceuticals (VNDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Lifecore Biomedical (LFCR) has outperformed Vanda Pharmaceuticals (VNDA) over the past year, losing 1.7% versus a loss of 23.5%. Over five years, LFCR leads with a -32.8% price change compared with -78.0% for VNDA. Vanda Pharmaceuticals is the larger company by market cap ($243.7 million vs $241.8 million), about 1.0 times the size.
Lifecore Biomedical converts more of its revenue into profit, with a net margin of -30.0% versus -102.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFCR | VNDA |
|---|---|---|
| Share price | $6.38 | $4.03 |
| Market cap | $241.84M | $243.66M |
| 1-day change | -0.93% | -4.95% |
| YTD return | -22.00% | -54.31% |
| 1-year return | -1.69% | -23.53% |
| 5-year return | -32.84% | -77.98% |
| Forward P/E | — | 20.15 |
| EPS (TTM) | $-1.27 | $-4.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $128.87M | $216.10M |
| Revenue growth (YoY) | +0.47% | +8.72% |
| Net income (latest FY) | $-38.72M | $-220.47M |
| Gross margin | 31.27% | 93.96% |
| Operating margin | -13.38% | -69.95% |
| Net margin | -30.04% | -102.02% |
| 52-week high | $8.98 | $9.94 |
| 52-week low | $3.63 | $4.00 |
| Distance from 52-week high | -28.95% | -59.46% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | -1.57% | +191.56% |
| Average volume | 330.83K | 968.38K |
| Shares outstanding | 37.91M | 60.46M |
| Employees | 382 | 533 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFCR has outperformed VNDA by 21.8 percentage points over the past year.
- Lifecore Biomedical is more profitable, keeping -30.0 cents of every revenue dollar as net income versus -102.0 cents for Vanda Pharmaceuticals.
- Vanda Pharmaceuticals grew revenue faster in its latest fiscal year (+8.72% vs +0.47%).
About Lifecore Biomedical
LFCR stock →Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
Health Care · Biotechnology: Pharmaceutical Preparations · 382 employees
About Vanda Pharmaceuticals
VNDA stock →Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion.
Health Care · Biotechnology: Pharmaceutical Preparations · 533 employees
LFCR vs VNDA FAQ
Which is bigger, Lifecore Biomedical or Vanda Pharmaceuticals?
Vanda Pharmaceuticals (VNDA) is larger, with a market capitalization of $243.66M compared with $241.84M for Lifecore Biomedical (LFCR).
Which stock has performed better over the past year, LFCR or VNDA?
LFCR returned -1.69% over the past 12 months, compared with -23.53% for VNDA (price return, excluding dividends). Past performance does not predict future results.
Are Lifecore Biomedical and Vanda Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.